Class summary at a glance.

Every drug in the Aminopenicillin (Antibiotic) class tracked across NADAC, Part D Formulary, Part D Spending, FDA Orange Book, and shortage data. Ranked below by CY24 Part D spend. Click any molecule for the full drug profile.

Molecules in class: 1tracked in Part D
CY24 Part D spend: $45.7Mcombined across class
Total Rx claims: 14.3M10.3M unique beneficiaries
Generic mfrs (active): 8across all molecules

Every drug in this class, ranked by Part D spend.

CY2024 dataCMS Part D Spending Dashboard

Amoxicillin

14.3M Part D claims (CY24) · 10.3M beneficiaries · First FDA approval: 1978-08-03

8 generic mfrs 0 plans require PA

Low NADAC$0.019

→

Avg plan cost$0.065

Part D spend $45.7M 4× spread, current vs floor

Class share

100%

of class CY24 spend

View profile →

Class summary at a glance.

Every drug in this class, ranked by Part D spend.

Related questions.